Hepatic encephalopathy in liver cirrhosis: pathogenesis, diagnosis and management (Q34127428)

31 July 2017

1 reference

title

Hepatic encephalopathy in liver cirrhosis: pathogenesis, diagnosis and management (English)

1 reference

31 July 2017

0 references

0 references

hepatic encephalopathy

1 reference

Gerber T

1

1 reference

PubMed ID

11152016

31 July 2017

Schomerus H

series ordinal

2

1 reference

31 July 2017

1 December 2000

1 reference

31 July 2017

1 reference

31 July 2017

60

1 reference

31 July 2017

6

1 reference

31 July 2017

1353-1370

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200060060-00008

31 July 2017

0 references

cites work

Synergism between mercaptans and ammonia or fatty acids in the production of coma: a possible role for mercaptans in the pathogenesis of hepatic coma

1 reference

12 December 2020

Somatosensory evoked potentials and number connection test in the detection of subclinical hepatic encephalopathy.

1 reference

12 December 2020

Cerebral changes in hepatic encephalopathy

1 reference

12 December 2020

High prevalence of sleep disturbance in cirrhosis.

1 reference

12 December 2020

Endogenous benzodiazepine receptor ligands in human and animal hepatic encephalopathy.

1 reference

12 December 2020

Elevated brain concentrations of 1,4-benzodiazepines in fulminant hepatic failure

1 reference

12 December 2020

Hepatic encephalopathy: comparative study of EEG abnormalities, neuropsychic disturbances and blood ammonia

1 reference

12 December 2020

Manganese and chronic hepatic encephalopathy

1 reference

12 December 2020

The role of plasma amino acids in hepatic encephalopathy

1 reference

12 December 2020

Evidence for the role of ammonia in the intracerebral transfer and metabolism of tryptophan.

1 reference

12 December 2020

Neuropharmacologic modulation of hepatic encephalopathy: experimental and clinical data.

1 reference

12 December 2020

Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study

1 reference

12 December 2020

Lactitol vs. lactulose in the treatment of acute hepatic encephalopathy in cirrhotic patients: a double-blind, randomized trial

1 reference

12 December 2020

Can hepatic coma be caused by a reduction of brain noradrenaline or dopamine?

1 reference

12 December 2020

[The disease picture of hepatic encephalopathy]

1 reference

12 December 2020

Brain microvessels take up large neutral amino acids in exchange for glutamine. Cooperative role of Na+-dependent and Na+-independent systems.

1 reference

12 December 2020

Hyperammonaemia and Helicobacter pylori

1 reference

12 December 2020

The reducing stent: treatment for transjugular intrahepatic portosystemic shunt-induced refractory hepatic encephalopathy and liver failure

1 reference

12 December 2020

Bright basal ganglia in T1-weighted magnetic resonance images are frequent in patients with portal vein thrombosis without liver cirrhosis and not suggestive of hepatic encephalopathy.

1 reference

12 December 2020

Treatment of cirrhotic hepatic encephalopathy with L-dopa. A controlled trial

1 reference

12 December 2020

Neuropsychological aspects of portal-systemic encephalopathy.

1 reference

12 December 2020

Flumazenil for hepatic encephalopathy grade III and IVa in patients with cirrhosis: an Italian multicenter double-blind, placebo-controlled, cross-over study

1 reference

12 December 2020

Latent portasystemic encephalopathy. I. Nature of cerebral functional defects and their effect on fitness to drive.

1 reference

12 December 2020

1 reference

12 December 2020

Treatment of chronic portal-systemic encephalopathy with lactose in lactase-deficient patients.

1 reference

12 December 2020

Hepatic encephalopathy and cerebral edema

1 reference

12 December 2020

Treatment of chronic portal systemic encephalopathy with bromocriptine: a double-blind controlled trial

1 reference

12 December 2020

Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: Clinical, laboratory, psychometric, and electroencephalographic investigations

1 reference

12 December 2020

Treatment of hepatic encephalopathy with metronidazole

1 reference

12 December 2020

Liver transplantation. American Association for the Study of Liver Diseases

1 reference

12 December 2020

Ammonia: key factor in the pathogenesis of hepatic encephalopathy

1 reference

12 December 2020

Regional blood-brain barrier permeability to amino acids after portacaval anastomosis.

1 reference

12 December 2020

The basal ganglia and portal-systemic encephalopathy

1 reference

12 December 2020

The diagnosis and prevalence of subclinical hepatic encephalopathy in apparently healthy, ambulant, non-shunted patients with cirrhosis

1 reference

12 December 2020

Acidifying enemas (lactitol and lactose) vs. nonacidifying enemas (tap water) to treat acute portal-systemic encephalopathy: a double-blind, randomized clinical trial

1 reference

12 December 2020

[Visual evoked potentials (VEP). Current perspectives]

1 reference

12 December 2020

False neurotransmitters and hepatic failure.

1 reference

12 December 2020

[Hepatic encephalopathy: neuropsychological and neurophysiological diagnosis]

1 reference

12 December 2020

Objective measurement of hepatic encephalopathy by means of automated EEG analysis

1 reference

12 December 2020

Helicobacter pylori and the liver: any relationship?

1 reference

12 December 2020

Surgical treatment of severe postshunt hepatic encephalopathy

1 reference

12 December 2020

Could an endogenous benzodiazepine ligand contribute to hepatic encephalopathy?

1 reference

12 December 2020

Neuropsychiatric complications following chlorothiazide therapy in patients with hepatic cirrhosis: possible relation to hypokalaemia

1 reference

12 December 2020

On therapy of hepatic coma with metabolites of the urea cycle, glutamate and alpha-ketoglutarate

1 reference

12 December 2020

MR imaging and (1)H spectroscopy of brain metabolites in hepatic encephalopathy: time-course of renormalization after liver transplantation

1 reference

12 December 2020

Lactulose and combination therapy of hepatic encephalopathy: the role of the intestinal microflora

1 reference

12 December 2020

The role of TIPS for the treatment of portal hypertension: effects and efficacy.

1 reference

12 December 2020

Overt hepatic encephalopathy precipitated by zinc deficiency

1 reference

12 December 2020

Cerebral benzodiazepine receptor binding in vivo in patients with recurrent hepatic encephalopathy

1 reference

12 December 2020

Urinary and serum octopamine in patients with portal-systemic encephalopathy

1 reference

12 December 2020

The first decade of the transjugular intrahepatic portosystemic shunt (TIPS): state of the art.

1 reference

12 December 2020

Increased availability of central benzodiazepine receptors in patients with chronic hepatic encephalopathy and alcohol related cirrhosis

1 reference

12 December 2020

Trailmaking and number-connection tests in the assessment of mental state in portal systemic encephalopathy.

1 reference

12 December 2020

The role of methanethiol in the pathogenesis of hepatic encephalopathy

1 reference

12 December 2020

Lactulose--a multifaceted substance

1 reference

12 December 2020

The auditory P300 event-related potential: an objective marker of the encephalopathy of chronic liver disease

1 reference

12 December 2020

Treatment of chronic portal-systemic encephalopathy with lactulose.

1 reference

12 December 2020

TREATMENT OF HEPATIC ENCEPHALOPATHY BY ALTERATION OF INTESTINAL FLORA WITH LACTOBACILLUS ACIDOPHILUS.

1 reference

12 December 2020

Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy

1 reference

12 December 2020

Successful use of bromocriptine in the treatment of chronic hepatic encephalopathy

1 reference

12 December 2020

Helicobacter pylori, hyperammonemia and subclinical portosystemic encephalopathy: effects of eradication.

1 reference

12 December 2020

Treatment of chronic portal--systemic encephalopathy with vegetable and animal protein diets. A controlled crossover study.

1 reference

12 December 2020

A new therapy for portal systemic encephalopathy.

1 reference

12 December 2020

Flumazenil therapy for hepatic encephalopathy in cirrhotic patients: a double-blind pragmatic randomized, placebo study

1 reference

12 December 2020

Prevalence of brain atrophy in liver cirrhosis patients with chronic persistent encephalopathy. Evaluation by computed tomography

1 reference

12 December 2020

Double-blind, double-dummy comparison between treatment with rifaximin and lactulose in patients with medium to severe degree hepatic encephalopathy.

1 reference

12 December 2020

Hyperammonaemia, plasma aminoacid imbalance, and blood-brain aminoacid transport: a unified theory of portal-systemic encephalopathy

1 reference

12 December 2020

Effects of ornithine aspartate on plasma ammonia and plasma amino acids in patients with cirrhosis. A double-blind, randomized study using a four-fold crossover design

1 reference

12 December 2020

Beneficial effect of carbohydrate maldigestion induced by a disaccharidase inhibitor (AO-128) in the treatment of chronic portal-systemic encephalopathy. A double-blind, randomized, controlled trial.

1 reference

12 December 2020

Neuropsychiatric profile and hyperintense globus pallidus on T1-weighted magnetic resonance images in liver cirrhosis.

1 reference

12 December 2020

Long-term treatment of latent portosystemic encephalopathy with branched-chain amino acids. A double-blind placebo-controlled crossover study

1 reference

12 December 2020

Long-term effects of Enterococcus faecium SF68 versus lactulose in the treatment of patients with cirrhosis and grade 1-2 hepatic encephalopathy.

1 reference

12 December 2020

Effect of flumazenil on the electroencephalogram of patients with portosystemic encephalopathy. Results of a double blind, randomised, placebo-controlled multicentre trial

1 reference

12 December 2020

Studies of the blood ammonia in liver disease. Its diagnostic, prognostic, and therapeutic significance

1 reference

12 December 2020

Multinuclear NMR spectroscopy studies on NH4Cl-induced metabolic alterations and detoxification processes in primary astrocytes and glioma cells

1 reference

12 December 2020

Subclinical hepatic encephalopathy: the diagnostic value of evoked potentials

1 reference

12 December 2020

Ammonia and glutamine metabolism of the intestine. The effect of lactulose and neomycin

1 reference

12 December 2020

Flash visual evoked responses in the early encephalopathy of chronic liver disease

1 reference

12 December 2020

Visual evoked potential--a tool in the diagnosis of hepatic encephalopathy?

1 reference

12 December 2020

Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial

1 reference

12 December 2020

Effect of vegetable and animal protein diets in chronic hepatic encephalopathy

1 reference

12 December 2020

Subclinical hepatic encephalopathy: detection, prevalence, and relationship to nitrogen metabolism

1 reference

12 December 2020

Mechanism of the excessive sedative response of cirrhotics to benzodiazepines: model experiments with triazolam.

1 reference

12 December 2020

Hepatic encephalopathy after transjugular intrahepatic portosystemic shunts: incidence and risk factors.

1 reference

12 December 2020

Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.

1 reference

12 December 2020

Encephalopathic effect of phenol in rats

1 reference

12 December 2020

Potential toxins of acute liver failure and their effects on blood-brain barrier permeability.

1 reference

12 December 2020

Transjugular intrahepatic portosystemic shunt and hepatic encephalopathy

1 reference

12 December 2020

Circulating noradrenaline and central haemodynamics in patients with cirrhosis.

1 reference

12 December 2020

Lactitol in treatment of chronic hepatic encephalopathy. A meta-analysis.

1 reference

12 December 2020

Hyperintense globus pallidus on T1-weighted MRI in cirrhotic patients is associated with severity of liver failure.

1 reference

12 December 2020

Treatment of hepatic encephalopathy

1 reference

12 December 2020

The electroencephalograph in liver disease

1 reference

12 December 2020

Parenteral nutrition with branched-chain amino acids in hepatic encephalopathy. A meta-analysis

1 reference

12 December 2020

Sodium benzoate in the treatment of acute hepatic encephalopathy: a double-blind randomized trial

1 reference

12 December 2020

Deafness Complicating Antibiotic Therapy of Hepatic Encephalopathy

1 reference

12 December 2020

Manganese in health and disease

1 reference

12 December 2020

Brain concentrations of benzodiazepines are elevated in an animal model of hepatic encephalopathy

1 reference

12 December 2020

Opioid receptor ligands in human hepatic encephalopathy

1 reference

12 December 2020

1 reference

12 December 2020

Branched chain amino acids in the treatment of latent portosystemic encephalopathy. A double-blind placebo-controlled crossover study

1 reference

12 December 2020

Lactitol or lactulose in the treatment of chronic hepatic encephalopathy: results of a meta-analysis

1 reference

12 December 2020

Experimental Hepatic Encephalopathy: Changes in the Binding of γ-Aminobutyric Acid

1 reference

12 December 2020

Auditory event-related cerebral potentials (P300) in hepatic encephalopathy--topographic distribution and correlation with clinical and psychometric assessment.

1 reference

12 December 2020

Effect of acute ammonia intoxication on cerebral metabolism in rats with portacaval shunts

1 reference

12 December 2020

Proton magnetic resonance spectroscopy: the new gold standard for diagnosis of clinical and subclinical hepatic encephalopathy?

1 reference

12 December 2020

Comparison of dietary protein with an oral, branched chain-enriched amino acid supplement in chronic portal-systemic encephalopathy: a randomized controlled trial.

1 reference

12 December 2020

Successful use of vancomycin hydrochloride in the treatment of lactulose resistant chronic hepatic encephalopathy

1 reference

12 December 2020

MRI findings in chronic hepatic encephalopathy depend on portosystemic shunt: results of a controlled prospective clinical investigation.

1 reference

12 December 2020

Lactobacillus acidophilus (Enpac) in Treatment of Hepatic Encephalopathy

1 reference

12 December 2020

Vegetable versus animal protein diet in cirrhotic patients with chronic encephalopathy. A randomized cross-over comparison

1 reference

12 December 2020

Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial

1 reference

12 December 2020

Increased blood-brain transfer in a rabbit model of acute liver failure

1 reference

12 December 2020

Flumazenil in cirrhotic patients in hepatic coma: a randomized double-blind placebo-controlled crossover trial.

1 reference

12 December 2020

10.2165/00003495-200060060-00008

Identifiers

DOI

1 reference

PubMed ID

11152016

Dimensions Publication ID

31 July 2017

0 references

1 reference

PubMed ID

11152016